Skip to main content
Diseases
Companies
News
Policy
About
Resources
Build with
KISHO
Sign In
Sign Up
Open menu
Kisho
ActiTrexx GmbH, University Medical Center of Johannes Gutenberg-University — Rare Disease Pipeline | Kisho | Kisho
ActiTrexx GmbH, University Medical Center of Johannes Gutenberg-University
Other
1
Orphan Designations
0
FDA Approvals
1
Rare Diseases
0
News Articles
Pipeline
Designations
News
Diseases
Disease
Drug(s)
Designation
Approved
graft versus host disease
CD4-mediated activated regulatory T cells
Orphan Designation
-
← Back to Companies
